CHOROIDAL NEOVASCULARIZATION

Clinical trials for CHOROIDAL NEOVASCULARIZATION explained in plain language.

Never miss a new study

Get alerted when new CHOROIDAL NEOVASCULARIZATION trials appear

Sign up with your email to follow new studies for CHOROIDAL NEOVASCULARIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

One-Shot gene therapy aims to free patients from monthly eye injections

Disease control Recruiting now

This study is testing a one-time gene therapy called RGX-314 for people with wet age-related macular degeneration (wet AMD), a leading cause of vision loss. The goal is to see if this single treatment can help the eye make its own medicine to control the disease, potentially redu…

Matched conditions: CHOROIDAL NEOVASCULARIZATION

Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control

Last updated Apr 01, 2026 22:47 UTC

CHOROIDAL NEOVASCULARIZATION

Get alerted when new CHOROIDAL NEOVASCULARIZATION trials appear

One-Shot gene therapy aims to free patients from monthly eye injections